Bendre S - Search Results

1

Centrosomal microtubule nucleation regulates radial migration of projection neurons independently of polarization in the developing brain.

Vinopal S, Dupraz S, Alfadil E, Pietralla T, Bendre S, Stiess M, Falk S, Camargo Ortega G, Maghelli N, Tolić IM, Smejkal J, Götz M, Bradke F. Vinopal S, et al. Among authors: bendre s. Neuron. 2023 Apr 19;111(8):1241-1263.e16. doi: 10.1016/j.neuron.2023.01.020. Epub 2023 Feb 15. Neuron. 2023. PMID: 36796357 Free article.

2

Clathrin's adaptor interaction sites are repurposed to stabilize microtubules during mitosis.

Rondelet A, Lin YC, Singh D, Porfetye AT, Thakur HC, Hecker A, Brinkert P, Schmidt N, Bendre S, Müller F, Mazul L, Widlund PO, Bange T, Hiller M, Vetter IR, Bird AW. Rondelet A, et al. Among authors: bendre s. J Cell Biol. 2020 Feb 3;219(2):e201907083. doi: 10.1083/jcb.201907083. J Cell Biol. 2020. PMID: 31932847 Free PMC article.

3

Synthesis and Preclinical Evaluation of Two Novel ⁶⁸Ga-Labeled Bispecific PSMA/FAP-Targeted Tracers with 2-Nal-Containing PSMA-Targeted Pharmacophore and Pyridine-Based FAP-Targeted Pharmacophore.

Verena A, Merkens H, Chen CC, Chapple DE, Wang L, Bendre S, Wong AAWL, Bénard F, Lin KS. Verena A, et al. Among authors: bendre s. Molecules. 2024 Feb 9;29(4):800. doi: 10.3390/molecules29040800. Molecules. 2024. PMID: 38398552 Free PMC article.

4

Development, preclinical evaluation and preliminary dosimetry profiling of SB03178, a first-of-its-kind benzo[h]quinoline-based fibroblast activation protein-α-targeted radiotheranostic for cancer imaging and therapy.

Bendre S, Merkens H, Kuo HT, Ng P, Wong AAWL, Lau WS, Zhang Z, Kurkowska S, Chen CC, Uribe C, Bénard F, Lin KS. Bendre S, et al. Eur J Med Chem. 2024 Mar 15;268:116238. doi: 10.1016/j.ejmech.2024.116238. Epub 2024 Feb 13. Eur J Med Chem. 2024. PMID: 38367492

5

Re-education of myeloid immune cells to reduce regulatory T cell expansion and impede breast cancer progression.

Gamage HEV, Shahoei SH, Albright ST, Wang Y, Smith AJ, Farmer R, Fink EC, Jacquin E, Weisser E, Bautista RO, Henn MA, Schane CP, Nelczyk AT, Ma L, Gupta AD, Bendre SV, Nguyen T, Tiwari S, Krawczynska N, He S, Tjoanda E, Chen H, Sverdlov M, Gann PH, Boidot R, Vegran F, Fanning SW, Apetoh L, Hergenrother PJ, Nelson ER. Gamage HEV, et al. Among authors: bendre sv. bioRxiv [Preprint]. 2023 Aug 14:2023.08.14.553229. doi: 10.1101/2023.08.14.553229. bioRxiv. 2023. PMID: 37645737 Free PMC article. Preprint.

6

Synthesis and Preclinical Evaluation of Novel ⁶⁸Ga-Labeled (R)-Pyrrolidin-2-yl-boronic Acid-Based PET Tracers for Fibroblast Activation Protein-Targeted Cancer Imaging.

Bendre S, Kuo HT, Merkens H, Zhang Z, Wong AAWL, Bénard F, Lin KS. Bendre S, et al. Pharmaceuticals (Basel). 2023 May 28;16(6):798. doi: 10.3390/ph16060798. Pharmaceuticals (Basel). 2023. PMID: 37375746 Free PMC article.

7

Synthesis and Evaluation of ⁶⁸Ga-Labeled (2S,4S)-4-Fluoropyrrolidine-2-Carbonitrile and (4R)-Thiazolidine-4-Carbonitrile Derivatives as Novel Fibroblast Activation Protein-Targeted PET Tracers for Cancer Imaging.

Bendre S, Zhang Z, Colpo N, Zeisler J, Wong AAWL, Bénard F, Lin KS. Bendre S, et al. Molecules. 2023 Apr 14;28(8):3481. doi: 10.3390/molecules28083481. Molecules. 2023. PMID: 37110717 Free PMC article.

8

Novel ⁶⁸Ga-Labeled Pyridine-Based Fibroblast Activation Protein-Targeted Tracers with High Tumor-to-Background Contrast.

Verena A, Kuo HT, Merkens H, Zeisler J, Bendre S, Wong AAWL, Bénard F, Lin KS. Verena A, et al. Among authors: bendre s. Pharmaceuticals (Basel). 2023 Mar 16;16(3):449. doi: 10.3390/ph16030449. Pharmaceuticals (Basel). 2023. PMID: 36986548 Free PMC article.

9

Synthesis and Preclinical Evaluation of Three Novel ⁶⁸Ga-Labeled Bispecific PSMA/FAP-Targeting Tracers for Prostate Cancer Imaging.

Verena A, Zhang Z, Kuo HT, Merkens H, Zeisler J, Wilson R, Bendre S, Wong AAWL, Bénard F, Lin KS. Verena A, et al. Among authors: bendre s. Molecules. 2023 Jan 21;28(3):1088. doi: 10.3390/molecules28031088. Molecules. 2023. PMID: 36770755 Free PMC article.

10

The nuclear receptor TLX (NR2E1) inhibits growth and progression of triple- negative breast cancer.

Nelczyk AT, Ma L, Gupta AD, Gamage HEV, McHenry MT, Henn MA, Kadiri M, Wang Y, Krawczynska N, Bendre S, He S, Shahoei SH, Madak-Erdogan Z, Hsiao SH, Saleh T, Carpenter V, Gewirtz DA, Spinella MJ, Nelson ER. Nelczyk AT, et al. Among authors: bendre s. Biochim Biophys Acta Mol Basis Dis. 2022 Nov 1;1868(11):166515. doi: 10.1016/j.bbadis.2022.166515. Epub 2022 Aug 4. Biochim Biophys Acta Mol Basis Dis. 2022. PMID: 35932893 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

29 results

Search Page